Lymphoma in human immunodeficiency virus infection. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Lymphoma in human immunodeficiency virus infection.

Diss Abstr Int [B]; 54(12):6127 1994. Unique Identifier : AIDSLINE ICDB/95607173
Boyle MJ; Univ. of New South Wales, Australia


Abstract: A clinical series of 41 HIV-associated NHL cases was analyzed. The findings confirmed, in an Australian population many features of HIV-associated NHL reported in other countries and suggested two definable groups of lymphoma patients: One with large cell immunoblastic histology, advanced immunodeficiency and a poor survival and another with small, noncleaved cell lymphoma, better preserved immune function and improved survival. To determine whether etiological factors may explain the patient survival differences, 20 HIV-associated NHL biopsies were investigated for HIV and EBV sequences using PCR. 10 samples (50%) harbored EBV, with 5 demonstrating A-type and 5 B-type EBV. HIV sequences were detected at an insignificant level. No patient had antibodies to HTLV-I. However, there was no survival difference between patients with A-type EBV, B-type EBV and without EBV in their tumors. The frequency of B-type EBV suggested B-type virus may be associated with immunodeficiency-associated lymphomas. This hypothesis was strengthened by assessing the EBV subtype in 30 Hodgkin's disease biopsies. Nine of the 30 cases had EBV in their malignant cells by in situ hybridization, 7 of A-type and 2 of B-type by PCR. The 2 B-type EBV cases had features suggesting immunodeficiency. To further explore EBV's role in HIV-associated NHL, 10 PGL cases were assessed for EBV and HIV sequences by PCR. HIV and EBV sequences were difficult to detect, suggesting direct infection of B cells by these viruses was not common in PGL. There followed studies to address whether the mechanisms of B cell activation in HIV infection contributed to lymphomagenesis, particularly the malignant transformation of EBV-infected B cells. The expression of IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, TNF-a and IFN-g was similar in both HIV and control reactive lymph nodes, as determined by PCR. The increased NHL incidence in HIV infection is thus probably not due to the profile of local cytokine production in PGL, though prolonged exposure of B cells to stimulatory cytokines may still be a key factor. The thesis advances a number of significant concepts in the study of immunodeficiency-associated and HIV-associated NHL, providing an important insight into the mechanisms of lymphomagenesis in these conditions. (Full text NOT AVAILABLE FROM UNIVERSITY MICROFILMS INT'L.)
Keywords: Cytokines/METABOLISM Herpesvirus 4, Human Human HIV Infections/*COMPLICATIONS/METABOLISM In Situ Hybridization Lymphoma, Non-Hodgkin's/*COMPLICATIONS/METABOLISM/VIROLOGY Polymerase Chain Reaction THESISKWDcytokines/metabolismherpesvirus4,humanhumanhivinfections/KWDcomplications/metabolisminsituhybridizationlymphoma,non-hodgkin's/KWDcomplications/metabolism/virologypolymerasechainreactionthesis
950430
M9541138

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .